KPV: Side effects, safety and status in 2026
KPV has never been tested in humans; therefore, its side effects in humans are unknown, and the FDA itself admits to lacking information on its safety. Here's what animal studies show, what the authorities say, and the risks associated with products sold online.
What we know, and what we don't know
No studies have measured the side effects of KPV in humans. In April 2026, the FDA stated that it had identified no data on human exposure, regardless of the route of administration, and lacked important information about its safety. Therefore, the lists of side effects found online are not based on any published studies.
What studies on cells and in animals show
- No pigmentation effect: Unlike whole alpha-MSH, KPV does not color the skin, according to a 2008 review.
- Nanoparticles that are well tolerated by cells: Two studies observed that KPV-loaded nanoparticles did not reduce the survival of intestinal cells in culture.
- Efficacy studies: Animal studies were looking for an effect on inflammation; they were not designed to measure toxicity.
The absence of adverse effects reported in these studies therefore does not prove that KPV is risk-free.
What the authorities are saying
| Authority | Date | Position |
|---|---|---|
| FDA (United States) | April 2026 | No human exposure data identified; safety information missing |
| FDA Advisory Committee | July 2026 | Favorable opinion for pharmacy preparations, contrary to the advice of FDA teams; non-binding opinion |
| U.S. Department of Health | October 30, 2026 | A provisional policy that tolerates these preparations under certain conditions; they are not approved medicines. |
| Europe and France | 2026 | No authorized medication; the ANSM (French National Agency for Medicines and Health Products Safety) issued a warning against peptides sold online in July 2026. |
No alerts specific to KPV have been found in Europe. KPV is not authorized there as a medicine: it is sold as a research peptide.
Anti-doping
The World Anti-Doping Agency's S0 class permanently prohibits any substance not approved as a medicine by any health authority. KPV is not explicitly mentioned in this classification, but it falls under this definition. WADA cites BPC-157 as an example of this class. A 2026 review also notes that KPV is among the peptides promoted in gyms.
The risks of products sold online
According to the same 2026 review, products sold outside of pharmaceutical channels are often mislabeled or contaminated. A vial may contain less than the advertised quantity, or a different product altogether. This is why an independent analysis report specific to the batch sold is necessary.
Check a batch of KPV
- A numbered report: the report must come from an independent laboratory, with a number and key verifiable on the laboratory's website.
- The measured quantity: It must be at least equal to the quantity stated on the vial.
- Purity: This is the proportion of intact KPV in the measured peptide.
- A recent date: the report must be less than one year old.
Our batch of KPV was analyzed by Janoshik on November 11, 2026: 11.07 mg measured per 10 mg vial, 98.8% purity. The page KPV COA explains how to verify it.
- KPV: The Complete Guide
- Benefits: what studies say
- Oral or injectable KPV: the forms studied
- KPV or BPC-157: the differences
- Our Janoshik (COA) analysis
- KLOW, a mixture that contains KPV
Frequently asked questions
What are the side effects of KPV?
These effects are not known in humans: no studies have measured them. The FDA says it lacks information on the safety of KPV.
Is KPV dangerous?
We don't know. The animal studies focused on efficacy, not toxicity, and there is no data available for humans.
Does KPV color the skin?
No. Unlike whole alpha-MSH, KPV has no pigmentary effect reported in studies.
Is KPV authorized in France?
It is not authorized as a medicine. It is sold as a research peptide, intended exclusively for scientific research.
Is KPV authorized in the United States?
This is not an approved medicine. Since the end of October 2026, a provisional policy has tolerated its preparation by pharmacies, under certain conditions.
Is KPV banned by WADA?
It falls into class S0, that of unapproved substances, permanently prohibited. It is not listed there by name.
Has KPV been the subject of any alerts?
No alerts specific to KPV were found. The ANSM issued a warning about peptides sold online in July 2026.
Are there any known interactions with KPV?
No data exists on the interactions of KPV, due to a lack of studies in humans.
How can you tell if a KPV is of good quality?
Request a report from an independent laboratory, with a verifiable number and key, a measured quantity and purity, dated less than one year ago.
Sources: FDA, substances for compounded preparations (April 2026); FDA advisory committee meeting of July 23-24, 2026; U.S. Department of Health, policy of October 30, 2026; ANSM, warning of July 2026; World Anti-Doping Agency, list of prohibited substances; Brzoska et al., Endocr Rev 2008; Laroui et al., Gastroenterology 2010; Xiao et al., Mol Ther 2017; Coutinho et al., J Sports Med Phys Fitness 2026; Janoshik report #248290. MyPeptide products are intended exclusively for scientific laboratory research.
